Controlling physiological angiogenesis by hypoxia-induced signaling

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Vascular Biology

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for tissue repair and development.
• Controlled angiogenesis is essential for therapeutic applications but challenging to achieve precisely.
• Tissue hypoxia is a known trigger for angiogenic factor cascades.

Purpose of the Study:

• To develop and validate a 3D in vitro model for testing localized hypoxic stimuli.
• To engineer a cell-based system for controlled induction of angiogenesis.
• To assess the efficacy of engineered Hypoxia-Induced Signaling (HIS) cells in promoting vascularization.

Main Methods:

• Designed a 3D collagen matrix model with spatially positioned cell depots.
• Engineered HIS cells from human dermal fibroblasts (HDFs) to create localized hypoxia.
• Co-cultured HIS cells with endothelial cells (ECs) to observe angiogenic responses.
• Implanted constructs in vivo and monitored vascularization and oxygen levels.

Main Results:

• HIS cell depots released angiogenic factors, inducing directional EC migration and tubule formation.
• Non-hypoxic controls showed minimal EC migration and tubule formation.
• HIS cell depots significantly accelerated host vessel in-growth into 3D constructs by at least 7 days.
• In vivo vascularization functionality was confirmed by real-time oxygen monitoring.

Conclusions:

• HIS cells effectively induce localized angiogenesis in a 3D model.
• The developed model allows for predictable control over vascularization.
• This approach holds promise for in vitro tissue modeling, implant vascularization, and therapeutic angiogenesis strategies.